Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

SIMPLE SUMMARY: The only vaccine approved by FDA as a treatment for cancer is sipuleucel-T, a therapy for patients with metastatic castration-resistant prostate cancer (mCRPC). Most investigators studying anti-tumor vaccines believe they will be most effective as parts of combination therapies, rath...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Gamat-Huber, Melissa, Jeon, Donghwan, Johnson, Laura E., Moseman, Jena E., Muralidhar, Anusha, Potluri, Hemanth K., Rastogi, Ichwaku, Wargowski, Ellen, Zahm, Christopher D., McNeel, Douglas G.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7601088/
https://ncbi.nlm.nih.gov/pubmed/33008010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102831
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados